Company Active LTD

Company profile

Octopus Investments Limited

UK company 03942880, incorporated on 8 March 2000.

A specialist real estate investor | Octopus Real Estate

Octopus Real Estate helps promote growth in the UK property market. We deliver finance supporting the entire lifecycle of real estate lending and investment.

Company number
03942880
Incorporated
8 Mar 2000
Companies House status
Active

Company identity

Founded / incorporated
8 March 2000

Company number 03942880

Verify at Companies House
Legal name
OCTOPUS INVESTMENTS LIMITED
Company type
Private Limited Company
Region
London
Registered address
6TH FLOOR, 33
HOLBORN
LONDON
EC1N 2HT
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

9 events
30 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

28 Jul
2026

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzUzNTQ5MTk1NGFkaXF6a2N4

Published 31 Jul 2026 16:19

03 Jul
2026

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzUzMDM0MDgxNmFkaXF6a2N4

Published 07 Jul 2026 15:06

11 Jun
2026

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzUyNjQ1MjgzNmFkaXF6a2N4

Published 19 Jun 2026 14:54

21 May
2026

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzUyMzA0NjM3NmFkaXF6a2N4

Published 26 May 2026 15:09

16 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

08 Mar
2000

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2020
Funded years
2020
Age at first award
20 years

Projects

2020 Collaborative R&D

Integrated Diagnostics for Early Diagnosis of Liver Disease [ID-LIVER]

1 Sep 2020 to 31 Aug 2023

Awarded
£0
Total cost £0

Liver disease is an epidemic with up to four in ten people having health problems from their liver not working properly. A proportion of these patients develop scarring that is most commonly picked up late but which can progress without stopping to complete liver failure. It is one of the UK's largest health challenges for which we do not have answers. At...

Product types

Collaborative R&D